Recap: Poseida Therapeutics Q4 Earnings
Poseida Therapeutics (NASDAQ:PSTX) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year.
Poseida Therapeutics To Present Interim Results From Phase 1 Trial Of P-PSMA-101 At ASCO Genitourinary Cancers Symposium Feb. 17-19
Poseida Therapeutics, Inc. (NASDAQ:PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 11)